Cargando…

The immune subtypes and landscape of sarcomas

BACKGROUND: Considering the molecular heterogeneity of sarcomas and their immunologically quiet character, immunotherapy (e.g., immune checkpoint inhibitors) plays a viable role in only a subset of these tumors. This study aimed to determine the immune subtypes (IMSs) of sarcomas for selecting suita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Weiwei, Yu, Lin, Li, Zhang, Tan, Cong, Lv, Jiaojie, Lao, I. Weng, Hu, Wenhuo, Deng, Zhenzhong, Liu, Zebing, Wang, Jian, Xu, Midie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508767/ https://www.ncbi.nlm.nih.gov/pubmed/36153483 http://dx.doi.org/10.1186/s12865-022-00522-3

Ejemplares similares

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
por: Dufresne, A., et al.
Publicado: (2020)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma
por: Zhang, Qiongyan, et al.
Publicado: (2019)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022)

The immune landscape of undifferentiated pleomorphic sarcoma
por: Lazcano, Rossana, et al.
Publicado: (2022)

Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature
por: Yu, Lin, et al.
Publicado: (2016)

Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity
por: Huang, Dan, et al.
Publicado: (2019)

The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
por: Gan, Lu, et al.
Publicado: (2018)

miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA
por: Ni, Shujuan, et al.
Publicado: (2018)

Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases
por: Ren, Fei, et al.
Publicado: (2019)

Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer
por: Yong, Wu, et al.
Publicado: (2018)

The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma
por: Deng, Yu, et al.
Publicado: (2019)

The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
por: Zhang, Meng, et al.
Publicado: (2018)

Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer
por: Wang, Xin, et al.
Publicado: (2020)

Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
por: Sun, Hui, et al.
Publicado: (2022)

Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
por: Wu, Wei, et al.
Publicado: (2023)

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
por: Que, Y, et al.
Publicado: (2018)

Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer
por: Sun, Hui, et al.
Publicado: (2018)

Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
por: Ni, Shujuan, et al.
Publicado: (2022)

Immune landscapes associated with different glioblastoma molecular subtypes
por: Martinez-Lage, Maria, et al.
Publicado: (2019)

The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer
por: Zhang, Minjie, et al.
Publicado: (2022)

Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas
por: Wang, Qifeng, et al.
Publicado: (2017)

OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer
por: Wang, Yiqin, et al.
Publicado: (2016)

LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer
por: Wang, Shunni, et al.
Publicado: (2020)

Metabolic landscapes in sarcomas
por: Miallot, Richard, et al.
Publicado: (2021)

Identification of glioblastoma immune subtypes and immune landscape based on a large cohort
por: Zhang, Huiyuan, et al.
Publicado: (2021)

Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile
por: Peng, Mou
Publicado: (2022)

The Landscape of Immunotherapy for Retroperitoneal Sarcoma
por: Gingrich, Alicia A., et al.
Publicado: (2023)

Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review
por: Lao, I Weng, et al.
Publicado: (2015)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort
por: Qi, Wenqian, et al.
Publicado: (2022)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer
por: Chen, Yuanmei, et al.
Publicado: (2022)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma
por: Zhang, Zhao, et al.
Publicado: (2022)

Single‐cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases
por: Sun, He‐Fen, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Exploring the landscape of immunotherapy approaches in sarcomas
por: Pilavaki, Pampina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3cparsbat7o930m8h71hsvodov